Insider Transactions in Q1 2024 at Immunovant, Inc. (IMVT)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 22
2024
|
Mark S. Levine Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
2,134
-0.7%
|
$76,824
$36.15 P/Share
|
|
Feb 22
2024
|
Eva Renee Barnett Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,930
-0.91%
|
$105,480
$36.15 P/Share
|
|
Feb 22
2024
|
Julia G. Butchko Chief Development Officer |
SELL
Open market or private sale
|
Direct |
2,146
-0.52%
|
$77,256
$36.15 P/Share
|
|
Feb 22
2024
|
William L. Macias Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
2,221
-0.67%
|
$79,956
$36.15 P/Share
|
|
Feb 22
2024
|
Peter Salzmann Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
13,454
-1.42%
|
$484,344
$36.15 P/Share
|
|
Jan 26
2024
|
Michael Geffner Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
10,101
-5.06%
|
$383,838
$38.18 P/Share
|
|
Jan 26
2024
|
Mark S. Levine Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
3,027
-0.49%
|
$115,026
$38.18 P/Share
|
|
Jan 18
2024
|
William L. Macias Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
424
-0.13%
|
$17,384
$41.03 P/Share
|
|
Jan 11
2024
|
Eva Renee Barnett Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,515
-0.54%
|
$147,630
$42.04 P/Share
|
|
Jan 05
2024
|
Julia G. Butchko Chief Development Officer |
SELL
Open market or private sale
|
Direct |
1,297
-0.32%
|
$49,286
$38.59 P/Share
|
|
Jan 05
2024
|
Peter Salzmann Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
3,824
-0.4%
|
$145,312
$38.59 P/Share
|